BLISS GVS PHARMA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.6 INR | -0.31% |
|
+10.61% | -8.79% |
| 20/06 | Crisil Keeps BBB+ Rating on Bliss GVS Pharma's Bank Loans; Outlook Stable | MT |
| 02/05 | Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
12.wbpdylhEZW-qYhsJwrDlw-xfFplZQR2NUOH3xCFf3Ho.h-4knD0NUAfpL2l8q9KOrbUnfsg6InfBCLaigGUpjheu9B6MMDUnHMcGeA~be758d7fb6c9709455e6e22f182748c2
